BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel


NEWSLETTERS
FREENewsletters
Archive

NEWS
News bySubject
News byDisease
News byDate
PLoS
SearchNews

CAREER NETWORK
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

DIVERSITY

HOTBEDS
Regional News
BiotechBay™
BiotechBeach™
Genetown™
PharmCountry™
BioCapital™
BioMidwest™
BioNC™
BioForest™
SouthernPharm™
BioCanadaEast™
US Device™

INVESTOR
Market Summary
News
IPOs

PROFILES
CompanyProfiles

START UPS
Companies
Events

INTELLIGENCE
BioPharm Insight

INDUSTRY EVENTS
Biotech Events
Post an Event

RESOURCES
RealEstate
Business Opportunities
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
NeurogesX, Inc. (OP: NGSX)
0.0110 USD  +0.0010 (+10.00%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 24, 2013  /  Add to My Watchlist      
View: Quote Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 13,390
Open 0.0120
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0100
Today's Range 0.0110 - 0.0150
52wk Range 0.0070 - 0.0160
Shares Outstanding 33,333,119
Dividend Yield N/A
Top News
More News
NeurogesX Reports Third Quarter 2012 Results
November 14, 2012
from GlobeNewswire News Releases
NeurogesX to Present at Rodman & Renshaw 14th Annual Healthcare Conference
September 05, 2012
from GlobeNewswire News Releases

More News
Read More
NeurogesX' NGX-1998 Well-Tolerated Treatment Demonstrated Clear Dose-Response in Patients
August 30, 2012
from GlobeNewswire News Releases
NeurogesX to Present at Wedbush PacGrow 2012 Life Sciences Management Access Conference
August 09, 2012
from GlobeNewswire News Releases
NeurogesX Provides Regulatory Update for NGX-1998 Clinical Program
August 07, 2012
from GlobeNewswire News Releases
NeurogesX Reports Second Quarter 2012 Results
August 03, 2012
from GlobeNewswire News Releases
NeurogesX Receives Additional Notice of Allowance Covering NGX-1998 in U.S.
August 02, 2012
from GlobeNewswire News Releases
NeurogesX to Hold Conference Call to Discuss Second Quarter 2012 Results
July 27, 2012
from GlobeNewswire News Releases
NeurogesX Partner Astellas Enrolls First Patient in EU Clinical Trial for QUTENZA(R) (8% capsaicin patch)
July 24, 2012
from GlobeNewswire News Releases
NeurogesX NGX-1998 Phase 2 Study Data to be Presented at World Congress on Pain
July 16, 2012
from GlobeNewswire News Releases
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
About BioSpace | Contact Us | Privacy Statement | Terms of Use
Post Your News | Post Event | Post Jobs | Post Company Profile | Advertising Opportunities

RSS FEED All News | Breaking News | Featured Stories

© 2007 BioSpace, Inc - an onTargetjobs company
Visit other onTargetjobs companies
Niche Job Boards | Biotechnology Jobs | Healthcare Jobs | Nursing Jobs | Accounting Jobs | Hospitality Jobs
Hospitality Jobs Canada | Hospitality Jobs UK